Summary:
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

measure amended introduced summary expanded action occurred measure transnational drug trafficking act sec bill amends controlled_substances_import_and_export_act broaden scope persons subject criminal prosecution manufacturing distributing controlled substance schedule precursor chemical flunitrazepam unlawful import united_states controlled substances act classifies drugs substances chemicals drugs schedules based drug medical use potential abuse risk dependence current law prohibits manufacture distribution person knows intends substance chemical unlawfully imported bill broadens scope prohibit manufacture distribution person reasonably believes substance chemical unlawfully imported addition bill prohibits manufacture distribution precursor chemical person knows intends chemical manufacture controlled substance knows intends reasonably believes controlled substance unlawfully imported united_states sec legislation amends federal criminal code replace statutory references prohibited trafficking counterfeit drug references prohibited trafficking drug uses counterfeit mark connection drug


Summary:
Mandatory Minimum Reform Act of 2015

This bill amends the Controlled Substances Act and the Controlled Substances Import and Export Act to eliminate most drug offense mandatory minimum prison terms imposed on a defendant who imports, exports, manufactures, distributes, or possesses with intent to distribute a controlled substance.

Additionally, it eliminates drug offense mandatory minimum prison terms for simple possession, distribution to an individual under age 21 by an individual under age 18, distribution or manufacture in a school zone, and use of an individual under age 21 to distribute.

Finally, the bill requires prior written approval of the Attorney General to prosecute a defendant for certain drug offenses that involve low-level drug quantities (e.g., less than one kilogram of heroin) or cocaine-based substances.

mandatory minimum reform act bill amends controlled substances act controlled_substances_import_and_export_act eliminate drug offense mandatory minimum prison terms imposed defendant imports exports manufactures distributes possesses intent distribute controlled substance additionally eliminates drug offense mandatory minimum prison terms simple possession distribution individual age individual age distribution manufacture school zone use individual age distribute finally bill requires prior written approval attorney general prosecute defendant certain drug offenses involve low level drug quantities heroin cocaine based substances


Summary:
Stop Civil Asset Forfeiture Funding for Marijuana Suppression Act of 2015

This bill prohibits the Department of Justice Assets Forfeiture Fund from being used for the Drug Enforcement Administration's (DEA's) Domestic Cannabis Suppression/Eradication Program or any substantially similar program.

No property may be transferred to a federal or state and local agency for purposes pertaining to such a program.

The bill expresses the sense of Congress that the DEA's marijuana prohibition policy is an inappropriate use of resources.

marijuana suppression act bill prohibits drug_enforcement_administration dea substantially similar program property transferred federal state local agency purposes pertaining program bill expresses sense congress dea marijuana prohibition policy inappropriate use resources


Summary:
Mandatory Minimum Reform Act of 2015

This bill amends the Controlled Substances Act and the Controlled Substances Import and Export Act to eliminate most drug offense mandatory minimum prison terms imposed on a defendant who imports, exports, manufactures, distributes, or possesses with intent to distribute a controlled substance.

Additionally, it eliminates drug offense mandatory minimum prison terms for simple possession, distribution to an individual under age 21 by an individual at least age 18, distribution or manufacture in a school zone, and use of an individual under age 18 to distribute.

Finally, the bill requires prior written approval of the Attorney General to prosecute a defendant for certain drug offenses that involve low-level drug quantities (e.g., less than one kilogram of heroin or less than 500 grams of cocaine-based substances).

mandatory minimum reform act bill amends controlled substances act controlled_substances_import_and_export_act eliminate drug offense mandatory minimum prison terms imposed defendant imports exports manufactures distributes possesses intent distribute controlled substance additionally eliminates drug offense mandatory minimum prison terms simple possession distribution individual age individual age distribution manufacture school zone use individual age distribute finally bill requires prior written approval attorney general prosecute defendant certain drug offenses involve low level drug quantities heroin grams cocaine based substances


Summary:
Dangerous Synthetic Drug Control Act of 2016

(Sec. 2) This bill amends the Controlled Substances Act to add certain synthetic opioids, hallucinogens, and cannabinoids to schedule I. (A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

dangerous synthetic drug control act sec bill amends controlled substances act add certain synthetic opioids schedule schedule controlled substance drug substance chemical high potential abuse currently accepted medical value subject regulatory controls administrative civil criminal penalties controlled substances act


Summary:
Respect States' and Citizens' Rights Act of 2015

This bill amends the Controlled Substances Act to declare that federal laws, including criminal penalties, are not intended to supersede or preempt state laws that pertain to marijuana.

bill amends controlled substances act declare federal laws including criminal penalties intended supersede preempt state laws pertain marijuana


Summary:
This bill revises and reauthorizes the Lake Tahoe Restoration Act for 10 fiscal years after the bill's enactment.

The bill adds requirements for the management of the Lake Tahoe Basin Management Unit, including requiring the U.S. Forest Service to:

 coordinate with the Environmental Protection Agency and state and local entities in managing the Basin; conduct forest management activities in the Basin in a manner that attains multiple ecosystem benefits, unless such activities would excessively increase the cost of any project; and establish and monitor post-program ground condition criteria for ground disturbance caused by forest management activities. The Forest Service may enter into contracts and cooperative agreements with government and other public and private entities to provide for fuel reduction, erosion control, reforestation, restoration, and similar activities in the Basin.

The bill mandates priority programs in the Basin, including programs for fire risk reduction and forest management, invasive species management, and stormwater management.

The bill requires relevant federal and state agencies, including the Tahoe Regional Planning Agency, and the states of California and Nevada, to develop and update an integrated multiagency assessment and monitoring plan to measure the effectiveness of the Agency's Environmental Improvement Program. The bill amends the Santini-Burton Act to authorize: (1) a donation from California to the Forest Service of lands administered by its agencies, and (2) a transfer from the Forest Service to Nevada of certain lands in the Basin.

bill revises reauthorizes lake_tahoe_restoration_act fiscal years bill enactment bill adds requirements management lake_tahoe_basin_management_unit including requiring coordinate environmental_protection_agency state local entities managing basin conduct forest management activities basin manner attains multiple ecosystem benefits activities excessively increase cost project establish monitor post program ground condition criteria ground disturbance caused forest management activities forest_service enter contracts cooperative agreements government public private entities provide fuel reduction erosion control reforestation restoration similar activities basin bill mandates priority programs basin including programs fire risk reduction forest management invasive species management stormwater management bill requires relevant federal state agencies including tahoe_regional_planning_agency states california nevada develop update integrated multiagency assessment monitoring plan measure effectiveness agency environmental_improvement_program bill amends santini burton act authorize donation california forest_service lands administered agencies transfer forest_service nevada certain lands basin


Summary:
Stop the Overdose Problem Already Becoming a Universal Substance Epidemic Act of 2015 or the STOP ABUSE Act of 2015

This bill requires the Department of Health and Human Services to convene an interagency task force to develop, solicit input on, disseminate information about, and study implementation of best practices for pain management and prescription of pain medication.

It amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Department of Justice to award grants:

 to implement comprehensive community-wide prevention strategies to address a rapid increase or high rate of opioid or prescription drug abuse; and to develop, implement, or expand treatment alternative to incarceration programs. This bill limits an individual's civil liability for harm caused by the emergency administration of an opioid overdose reversal drug (e.g., naloxone) if the individual:

 works or volunteers at an opioid overdose program and provides the drug, as a part the program, to an authorized individual who administers it; or administers the drug after obtaining it from a health care professional or as part of an opioid overdose program, or administers it pursuant to a prescription, and was educated on its administration. It amends the Controlled Substances Act to require an opioid treatment program that closes on any day to make arrangements for each patient to receive treatment during the closure, as necessary.

The bill reauthorizes the High Intensity Drug Trafficking Areas program through FY2020.

It amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a specified purpose of state-administered controlled substance monitoring systems ensuring that appropriate authorities have access to prescription history information for investigations.

The bill amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program.

stop universal substance epidemic act stop abuse act bill requires department_of_health_and_human_services convene interagency task force develop solicit input disseminate information study implementation best practices pain management prescription pain medication amends omnibus_crime_control_and_safe_streets_act authorize department_of_justice award grants implement comprehensive community wide prevention strategies address rapid increase high rate opioid prescription drug abuse develop implement expand treatment alternative incarceration programs bill limits individual civil liability harm caused emergency administration opioid overdose reversal drug naloxone individual works volunteers opioid overdose program provides drug program authorized individual administers administers drug obtaining health care professional opioid overdose program administers pursuant prescription educated administration amends controlled substances act require opioid treatment program closes day arrangements patient receive treatment closure necessary bill reauthorizes program fy2020 amends include specified purpose state administered controlled substance monitoring systems ensuring appropriate authorities access prescription history information investigations bill amends public_health_service_act revise reauthorize fy2020 controlled substance monitoring program


Summary:
State Marihuana And Regulatory Tolerance Enforcement Act

This bill amends the Controlled Substances Act to prohibit federal enforcement of marijuana offenses in a state that: (1) requests a waiver from the Department of Justice (DOJ) certifying that it legalized marijuana; (2) demonstrates a regulatory scheme sufficient to protect federal interests (e.g., preventing marijuana distribution to minors); and (3) agrees to study and report on certain outcomes.

DOJ may revoke the waiver of a state that fails to meets the conditions.

state marihuana regulatory tolerance enforcement act bill amends controlled substances act prohibit federal enforcement marijuana offenses state requests waiver department_of_justice doj certifying marijuana demonstrates regulatory scheme sufficient protect federal interests preventing marijuana distribution minors agrees study report certain outcomes doj revoke waiver state fails meets conditions


Summary:
Stop Meth Labs and Enhance Patient Access Act of 2015

This bill amends the Controlled Substances Act to revise the standard used by the Drug Enforcement Administration (DEA) to determine whether to exempt a scheduled listed chemical product from certain applicable requirements. (A scheduled listed chemical product is a nonprescription drug product that contains ephedrine, pseudoephedrine, or phenylpropanolamine.)

Currently, the DEA may exempt retail sales of a scheduled listed chemical product from certain requirements (e.g., daily sales limits) if the product cannot be used to illegally manufacture methamphetamine. This bill allows the DEA to exempt retail sales of a scheduled listed chemical product from such requirements if it is not practical by processes known to be employed by clandestine laboratory operators to use the product to illegally manufacture methamphetamine.

stop labs enhance patient access act bill amends controlled substances act revise standard drug_enforcement_administration dea determine exempt scheduled listed chemical product certain applicable requirements scheduled listed chemical product nonprescription drug product contains currently dea exempt retail sales scheduled listed chemical product certain requirements daily sales limits product illegally manufacture methamphetamine bill allows dea exempt retail sales scheduled listed chemical product requirements practical processes known employed clandestine laboratory operators use product illegally manufacture methamphetamine


Summary:
Stop Trafficking in Fentanyl Act of 2015

 This bill amends the Controlled Substances Act to modify the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, or possesses with intent to distribute fentanyl.

Specifically, the bill reduces from 400 to 20 grams the fentanyl quantity and from 100 to 5 grams the fentanyl analogue quantity that trigger a 10-year or 20-year mandatory minimum prison term for high-level first-time or repeat offenders. It also reduces from 40 to 2 grams the fentanyl quantity and from 10 to 0.5 grams the fentanyl analogue quantity that trigger a 5-year or 10-year mandatory minimum prison term for low-level first-time or repeat offenders.

stop trafficking bill amends controlled substances act modify drug quantity thresholds trigger mandatory minimum prison term defendant manufactures distributes possesses intent distribute fentanyl specifically bill reduces grams fentanyl quantity grams fentanyl analogue quantity trigger year year mandatory minimum prison term high level time repeat offenders reduces grams fentanyl quantity grams fentanyl analogue quantity trigger year year mandatory minimum prison term low level time repeat offenders


Summary:
Protecting Patient Access to Emergency Medications Act of 2016

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

act sec bill amends controlled substances act direct drug_enforcement_administration dea register emergency medical services ems agency administer controlled substances agency submits application demonstrating authorized conduct activity state agency practices dea deny application determines registration inconsistent public interest ems agency obtain single registration state instead separate registration location registered ems agency deliver store receive controlled substances subject specified conditions ems professional registered ems agency administer controlled substances schedules iii outside physical presence medical director administration authorized state law pursuant standing verbal order subject specified conditions bill specifies hospital based ems agency ems agency owned operated hospital continue administer controlled substances hospital dea registration


Summary:
Marijuana Advertising in Legal States Act of 2016 or the MAILS Act

This bill amends the Controlled Substances Act to modify the application of a provision that limits advertisements with respect to certain controlled substances.

Currently, it is a crime to knowingly place a written advertisement in a newspaper, magazine, handout, or other publication for the purpose of receiving, buying, or distributing a schedule 1 controlled substance (e.g., marijuana). This legislation declares that the prohibition does not apply with respect to an advertisement for a marijuana-related activity that complies with state law.

legal states act mails act bill amends controlled substances act modify application provision limits advertisements respect certain controlled substances currently crime knowingly place written advertisement newspaper magazine publication purpose receiving buying distributing schedule controlled substance marijuana legislation declares prohibition apply respect advertisement marijuana related activity complies state law


Summary:
(This measure has not been amended since it was reported to the House on May 10, 2016. The summary of that version is repeated here.)

Reducing Unused Medications Act of 2016

(Sec. 2) This bill amends the Controlled Substances Act to allow a pharmacist to partially fill a prescription for a schedule II controlled substance (such as a prescription opioid painkiller) if: (1) it is not prohibited by state law, (2) it is prescribed in accordance with existing laws and regulations, (3) it is requested by the patient or prescribing practitioner, and (4) the total quantity dispensed in partial fillings does not exceed the total quantity prescribed.

Additionally, a pharmacist may partially fill a prescription for a schedule II controlled substance in other circumstances in accordance with existing Drug Enforcement Administration (DEA) regulations. (Current DEA regulations permit partial fills when a pharmacist cannot supply a full quantity, a patient resides in a long-term care facility, or a patient is terminally ill.)

The remaining portion of a partially filled prescription may be filled within 30 days or, in the case of an emergency situation, within 72 hours.

measure amended reported house summary version repeated reducing unused medications act sec bill amends controlled substances act allow pharmacist partially fill prescription schedule controlled substance prescription opioid prohibited state law prescribed accordance existing laws regulations requested patient prescribing practitioner total quantity dispensed partial fillings exceed total quantity prescribed additionally pharmacist partially fill prescription schedule controlled substance circumstances accordance existing drug_enforcement_administration dea regulations current dea regulations permit partial fills pharmacist supply quantity patient resides long term care facility patient terminally ill remaining portion partially filled prescription filled days case emergency situation hours


Summary:
Keeping Communities Safe through Treatment Act of 2016

This bill directs the Department of Justice to establish a pilot program to provide grants to law enforcement agencies in designated high intensity drug trafficking areas for programs to divert low-level drug offenders to drug treatment programs.

keeping communities safe treatment act bill directs department_of_justice establish pilot program provide grants law enforcement agencies designated high intensity drug trafficking areas programs divert low level drug offenders drug treatment programs


Summary:
CBD Oil Act of 2016

This bill amends the Controlled Substances Act to bar the federal prosecution of an individual who produces, distributes, or uses CBD oil for medical research or medical purposes in compliance with state law.

The term "CBD oil" means a marijuana extract that is composed of a nonpsychoactive proportion of tetrahydrocannabinol and cannabidiol under state law.

oil act bill amends controlled substances act bar federal prosecution individual produces distributes uses oil medical research medical purposes compliance state law term oil means marijuana extract composed proportion tetrahydrocannabinol cannabidiol state law


Summary:
Opioid Use Disorder Treatment Expansion and Modernization Act

(Sec. 3) This bill amends the Controlled Substances Act to revise the requirements for a practitioner to administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.

Currently, a practitioner must notify the Department of Health and Human Services (HHS) and certify that he or she is a qualifying physician (i.e., a state-licensed physician with certain expertise), has the capacity to refer patients for appropriate counseling and ancillary services, and will comply with a patient limit. The patient limit is how many patients the practitioner can treat under the office-based treatment program at one time.

This legislation expands qualifying practitioners to include nurse practitioners and physician assistants who are licensed in a state, have expertise (such as relevant training or expertise), and prescribe medications for opioid use disorder in collaboration with or under the supervision of a qualifying physician if state law requires physician oversight of prescribing authority.

Additionally, it requires a qualifying practitioner to also certify that he or she will comply with reporting requirements and has the capacity to provide directly or by referral, or in another manner prescribed by HHS, all drugs approved by the Food and Drug Administration to treat opioid use disorder.

HHS may issue regulations to change the maximum patient limit for a qualifying practitioner. If HHS increases the limit, then a qualifying practitioner must additionally certify that he or she will obtain written consent from each patient regarding available treatment options.

HHS must update the treatment improvement protocol containing best practice guidelines for the treatment of opioid-dependent patients in office-based settings.

HHS may recommend revoking or suspending the registration of a practitioner who fails to comply with the requirements of this Act.

(Sec. 4) The bill expresses the sense of Congress that HHS should consider raising from 100 to 250 the maximum patient limit for a qualifying physician.

(Sec. 5) It amends the Controlled Substances Act to allow a pharmacist to partially fill a prescription for a schedule II controlled substance (such as a prescription opioid painkiller) if: (1) it is not prohibited by state law, (2) it is prescribed in accordance with existing laws and regulations, (3) it is requested by the patient or prescribing practitioner, and (4) the total quantity dispensed in partial fillings does not exceed the total quantity prescribed.

Additionally, a pharmacist may partially fill a prescription for a schedule II controlled substance in other circumstances in accordance with existing Drug Enforcement Administration (DEA) regulations. (Current DEA regulations permit partial fills when a pharmacist cannot supply a full quantity, a patient resides in a long-term care facility, or a patient is terminally ill.)

The remaining of a partially filled prescription may be filled within 30 days or, in the case of an emergency situation, within 72 hours.

opioid use disorder treatment expansion modernization act sec bill amends controlled substances act revise requirements practitioner administer dispense prescribe narcotic drugs maintenance detoxification treatment office based opioid treatment program currently practitioner notify department_of_health_and_human_services hhs certify qualifying physician state licensed physician certain expertise capacity refer patients appropriate counseling ancillary services comply patient limit patient limit patients practitioner treat office based treatment program time legislation expands qualifying practitioners include nurse practitioners physician assistants licensed state expertise relevant training expertise prescribe medications opioid use disorder collaboration supervision qualifying physician state law requires physician oversight prescribing authority additionally requires qualifying practitioner certify comply reporting requirements capacity provide directly referral manner prescribed hhs drugs approved food_and_drug_administration treat opioid use disorder hhs issue regulations change maximum patient limit qualifying practitioner hhs increases limit qualifying practitioner additionally certify obtain written consent patient available treatment options hhs update treatment improvement protocol containing best practice guidelines treatment opioid dependent patients office based settings hhs recommend revoking suspending registration practitioner fails comply requirements act sec bill expresses sense congress hhs consider raising maximum patient limit qualifying physician sec amends controlled substances act allow pharmacist partially fill prescription schedule controlled substance prescription opioid prohibited state law prescribed accordance existing laws regulations requested patient prescribing practitioner total quantity dispensed partial fillings exceed total quantity prescribed additionally pharmacist partially fill prescription schedule controlled substance circumstances accordance existing drug_enforcement_administration dea regulations current dea regulations permit partial fills pharmacist supply quantity patient resides long term care facility patient terminally ill remaining partially filled prescription filled days case emergency situation hours


Summary:
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Kingpin Designation Improvement Act of 2016

(Sec. 2) This bill amends the Foreign Narcotics Kingpin Designation Act to allow classified information to be submitted to a reviewing court ex parte or in camera in a judicial review of a determination by the President that a foreign person is subject to sanctions as a significant foreign narcotics trafficker.

measure amended introduced summary expanded action occurred measure improvement act sec bill amends foreign_narcotics_kingpin_designation_act allow classified information submitted reviewing court parte camera judicial review determination president foreign person subject sanctions significant foreign narcotics trafficker


Summary:
Comprehensive Opioid Abuse Reduction Act of 2016

(Sec. 2) This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Department of Justice (DOJ) to award grants to state, local, and tribal governments to provide opioid abuse services, including:

 enhancing collaboration between criminal justice and substance abuse agencies; developing, implementing, or expanding programs to prevent, treat, or respond to opioid abuse; training first responders to administer opioid overdose reversal drugs; and investigating unlawful opioid distribution activities. (Sec. 3) DOJ's Office of Inspector General must conduct annual audits of selected grant recipients. The bill prohibits grants to nonprofit organizations that hold money in an offshore account to avoid tax liability.

(Sec. 4) The bill also authorizes DOJ to award grants to state, local, and tribal governments to establish or expand programs for veterans, including:

 veterans treatment courts; peer-to-peer services; treatment, rehabilitation, legal, or transitional services to incarcerated veterans; or training for relevant personnel to identify and appropriately respond to incidents. (Sec. 5) To offset the cost, the bill amends the Justice Assistance Act of 1984 to eliminate existing authority for DOJ to award grants under the Emergency Federal Law Enforcement Assistance Program through FY2021.

(Sec. 6) It expands specified grant purposes under the Family-Based Substance Abuse Treatment Program to include prison-based family treatment programs for pregnant women.

(Sec. 7) The Government Accountability Office must study and report to Congress on how DOJ grant programs address the prevention of, treatment for, and recovery from substance use and substance use disorders among adolescents and young adults.

comprehensive opioid abuse reduction act sec bill amends omnibus_crime_control_and_safe_streets_act authorize department_of_justice doj award grants state local tribal governments provide opioid abuse services including enhancing collaboration criminal justice substance abuse agencies developing implementing expanding programs prevent treat respond opioid abuse training responders administer opioid overdose reversal drugs investigating unlawful opioid distribution activities sec doj office_of_inspector_general conduct annual audits selected grant recipients bill prohibits grants nonprofit organizations hold money offshore account avoid tax liability sec bill authorizes doj award grants state local tribal governments establish expand programs veterans including veterans treatment courts peer peer services treatment rehabilitation legal transitional services incarcerated veterans training relevant personnel identify appropriately respond incidents sec offset cost bill amends justice assistance act eliminate existing authority doj award grants emergency federal law enforcement assistance program fy2021 sec expands specified grant purposes include prison based family treatment programs pregnant women sec government_accountability_office study report congress doj grant programs address prevention treatment recovery substance use substance use disorders adolescents young adults


Summary:
(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)

Good Samaritan Assessment Act of 2016

(Sec. 3) This bill requires the Government Accountability Office to submit a report about the Office of National Drug Control Policy's (ONDCP's) review of state and local Good Samaritan laws that exempt from criminal or civil liability any individual who administers an opioid overdose reversal drug or device or who contacts emergency services providers in response to an overdose. The report must: (1) address the extent to which the ONDCP has reviewed such Good Samaritan laws, including any findings related to the potential effects of such laws; (2) describe the ONDCP's efforts to encourage enactment of such laws; and (3) provide a compilation of such Good Samaritan laws in effect in states.

(Sec. 4) For purposes of the report, "opioid" means any drug, including heroin, having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability.

measure amended introduced expanded summary house reported version repeated good samaritan assessment act sec bill requires government_accountability_office submit report office_of_national_drug_control_policy review state local good samaritan laws exempt criminal civil liability individual administers opioid overdose reversal drug device contacts emergency services providers response overdose report address extent reviewed good samaritan laws including findings related potential effects laws describe efforts encourage enactment laws provide compilation good samaritan laws effect states sec purposes report opioid means drug including heroin having addiction forming addiction sustaining liability similar capable conversion drug having addiction forming addiction sustaining liability


Summary:
Opioid Abuse Crisis Act of 2016

This bill appropriates funding for activities in this bill.

This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to provide support for activities related to opioid abuse, including treatment services. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

This bill amends the Controlled Substances Act, including to permit a pharmacist to partially fill a prescription for certain drugs.

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to refer new drug applications for opioids without abuse deterrent properties to an advisory committee.

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to permit the Department of Justice (DOJ) to support opioid abuse services and programs for veterans.

Opioid Program Evaluation Act or the OPEN Act

DOJ and HHS must have a nonfederal entity evaluate the grants established by this bill.

Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act

The Department of Veterans Affairs (VA) and the Department of Defense (DOD) must update the VA/DOD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain.

The VA must carry out activities related to opioid abuse, including expanding the opioid safety initiative to include all VA medical facilities.

Improving Safe Care for the Prevention of Infant Abuse and Neglect Act

The national clearinghouse for child abuse information must provide information on plans of safe care for infants born affected by substance abuse.

This bill amends the Social Security Act, including to permit prescription drug plan sponsors to establish programs for beneficiaries at-risk for prescription drug abuse.

opioid abuse crisis act bill appropriates funding activities bill bill amends public_health_service_act require department_of_health_and_human_services hhs provide support activities related opioid abuse including treatment services opioids drugs effects similar opium heroin certain pain medications bill amends controlled substances act including permit pharmacist partially fill prescription certain drugs bill amends cosmetic act require food_and_drug_administration refer new drug applications opioids abuse deterrent properties advisory committee bill amends omnibus_crime_control_and_safe_streets_act permit department_of_justice doj support opioid abuse services programs veterans open act doj hhs nonfederal entity evaluate grants established bill promoting responsible opioid management incorporating scientific expertise act promise act department_of_veterans_affairs department_of_defense dod update chronic pain carry activities related opioid abuse including expanding opioid safety initiative include medical facilities improving safe care prevention neglect act national clearinghouse child abuse information provide information plans safe care infants born affected substance abuse bill amends social security act including permit prescription drug plan sponsors establish programs beneficiaries risk prescription drug abuse


Summary:
Top 1% Accountability Act

This bill amends the Internal Revenue Code to prohibit an individual from itemizing deductions for a year if: (1) the sum of the taxpayer's itemized deductions equals or exceeds $150,000, and (2) the taxpayer (and the taxpayer's spouse for a joint return) fails to submit proof of a clean drug test with the return. The drug test must show that the taxpayer (and the taxpayer's spouse for a joint return) did not test positive for any controlled substance.

accountability act bill amends internal_revenue_code prohibit individual deductions year sum taxpayer itemized deductions equals exceeds taxpayer taxpayer spouse joint return fails submit proof clean drug test return drug test taxpayer taxpayer spouse joint return test positive controlled substance


Summary:
Medical Marijuana Research Act of 2016

This bill amends the Controlled Substances Act to:

 modify requirements regarding the production of marijuana through the National Institute on Drug Abuse Drug Supply Program; establish, with respect to marijuana research, a new federal registration process that is separate from the process for research involving other schedule I drugs; establish a process for registering persons to manufacture or distribute marijuana for medical research purposes; and modify other requirements related to marijuana research and production.

medical marijuana research act bill amends controlled substances act modify requirements production marijuana establish respect marijuana research new federal registration process separate process research involving schedule drugs establish process registering persons manufacture distribute marijuana medical research purposes modify requirements related marijuana research production


Summary:
Foreign Investment and Economic Security Act of 2016

This bill amends the Defense Production Act of 1950 to provide for: (1) national security reviews of transactions involving the construction of a new facility in the United States by any foreign person (currently, national security reviews are conducted only for certain mergers, acquisitions, or takeovers by or with a foreign person); and (2) net benefit reviews of new construction, mergers, acquisitions, or takeovers by or with a foreign person to determine whether the transaction is of net benefit to the United States.

The bill makes net benefit reviews mandatory for transactions that meet specified requirements under the Clayton Act.

The bill requires the Committee on Foreign Investment in the United States (CFIUS), for purposes of carrying out net benefit determinations, to consider the effect of the transaction on: (1) employment, resource processing, the utilization of parts and services produced in or imported into the United States, and exports; (2) industrial efficiency, technological development, technology transfers, and product innovation; (3) competition within any U.S. industry or with other countries; (4) compatibility with national industrial, economic, and cultural policies; and (5) public health, safety, and well-being of U.S. consumers.

 In the case of a net benefit determination concerning a foreign government-influenced transaction, CFIUS must consider additional factors including:

 the governance and commercial orientation of the foreign person engaging in such transaction; the extent to which the foreign person is owned, controlled, or influenced by the foreign government; and adherence to U.S. law and corporate governance standards, engagement of the foreign country with the Securities and Exchange Commission and the Public Company Accounting Oversight Board, and the likelihood of operation on a commercial basis. The bill also revises the composition of CFIUS, for the purpose of carrying out net benefit determinations.

The bill requires final CFIUS determinations to be certified to Congress and referred to the President if a transaction will not be of net benefit to the United States. The bill prohibits transactions that the President determines are not of net benefit to the United States and bars judicial review of such determinations.

security act bill amends defense production act provide national security reviews transactions involving construction new facility united_states foreign person currently national security reviews conducted certain mergers acquisitions foreign person net benefit reviews new construction mergers acquisitions foreign person determine transaction net benefit united_states bill makes net benefit reviews mandatory transactions meet specified requirements clayton act bill requires united_states purposes carrying net benefit determinations consider effect transaction employment resource processing utilization parts services produced imported united_states exports industrial efficiency technological development technology transfers product innovation competition industry countries compatibility national industrial economic cultural policies public health safety consumers case net benefit determination concerning foreign government influenced transaction consider additional factors including governance commercial orientation foreign person engaging transaction extent foreign person owned controlled influenced foreign government adherence law corporate governance standards engagement foreign country securities_and_exchange_commission public_company_accounting_oversight_board likelihood operation commercial basis bill revises composition purpose carrying net benefit determinations bill requires final determinations certified congress referred president transaction net benefit united_states bill prohibits transactions president determines net benefit united_states bars judicial review determinations


Summary:
Dangerous Synthetic Drug Control Act of 2016

This bill amends the Controlled Substances Act to add certain synthetic opioids, hallucinogens, and cannabinoids to schedule I. (A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

dangerous synthetic drug control act bill amends controlled substances act add certain synthetic opioids schedule schedule controlled substance drug substance chemical high potential abuse currently accepted medical value subject regulatory controls administrative civil criminal penalties controlled substances act


Summary:
Ready to Work Act of 2016

This bill amends title III (Unemployment Insurance) of the Social Security Act to allow states, rather than the Department of Labor, to determine whether an individual claiming unemployment compensation is an individual for whom suitable work is only available in an occupation that regularly conducts drug testing.

The final rule issued by Labor on August 1, 2016, entitled "Federal-State Unemployment Compensation Program; Middle Class Tax Relief and Job Creation Act of 2012 Provision on Establishing Appropriate Occupations for Drug Testing of Unemployment Compensation Applicants" (81 Fed. Reg. 50298), shall have no force or effect.

ready work act bill amends title social security act allow states department_of_labor determine individual claiming unemployment compensation individual suitable work available occupation regularly conducts drug testing final rule issued labor august entitled federal state unemployment compensation program middle class tax relief job creation act provision establishing appropriate occupations drug testing unemployment compensation applicants fed shall force effect


Summary:
Synthetic Drug Overdose Prevention and Education Act

This bill amends the Public Health Service Act to require the Centers for Disease Control and Prevention (CDC) to study strategies for preventing and treating the use of synthetic recreational drugs, which are substances marketed for recreational use (regardless of claims to the contrary) that are analogous to a controlled substance and are not medications.

The Department of Health and Human Services must coordinate with the Drug Enforcement Administration (DEA) to establish and maintain a database of synthetic recreational drugs. The database must be publicly available for use in preventing and treating the use of synthetic recreational drugs.

The CDC, in collaboration with the Substance Abuse and Mental Health Services Administration, the National Institute on Drug Abuse, the National Institutes of Health, and the DEA, must develop and implement a national outreach campaign to educate law enforcement personnel, health care professionals, community members, and others about preventing and treating the use of substances similar to marijuana (cannabimimetic agents).

The CDC may award grants to federally qualified health centers for public awareness programs regarding substances similar to marijuana.

bill amends public_health_service_act require centers_for_disease_control_and_prevention cdc study strategies preventing treating use synthetic recreational drugs substances marketed recreational use regardless claims contrary analogous controlled substance medications department_of_health_and_human_services coordinate drug_enforcement_administration dea establish maintain database synthetic recreational drugs database publicly available use preventing treating use synthetic recreational drugs cdc collaboration substance_abuse_and_mental_health_services_administration national_institutes_of_health dea develop implement national outreach campaign educate law enforcement personnel health care professionals community members preventing treating use substances similar marijuana cannabimimetic agents cdc award grants federally qualified health centers public awareness programs substances similar marijuana


Summary:
Help Ensure Lives are Protected Act of 2016 or the HELP Act of 2016

This bill amends the Controlled Substances Act and the Controlled Substances Import and Export Act to impose a criminal penalty of life imprisonment or death on a person who commits a drug offense involving a specified quantity of heroin that contains a detectable amount of fentanyl or fentanyl that is represented to be or sold as heroin, if death or serious bodily injury results from the use of such substance.

help ensure lives protected act help act bill amends controlled substances act controlled_substances_import_and_export_act impose criminal penalty life imprisonment death person commits drug offense involving specified quantity heroin contains detectable fentanyl fentanyl represented sold heroin death bodily injury results use substance


Summary:
Heroin and Opioid Abuse Prevention and Treatment Act of 2016

This bill amends the Internal Revenue Code to require manufacturers, producers, and importers of active opioids to pay an excise tax of one cent per milligram of opioid.

The bill also amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to provide grants to states for: (1) research on opioids (including heroin), and (2) opioid abuse prevention and treatment.

The Department of the Treasury must transfer an amount equal to the revenue collected from the tax to HHS to carry out this bill. The bill makes the funds available without further appropriation and designates the funding as an emergency requirement under the Statutory Pay-As-You-Go Act of 2010 (PAYGO).

heroin opioid abuse prevention treatment act bill amends internal_revenue_code require manufacturers producers importers active opioids pay excise tax cent opioid bill amends public_health_service_act require department_of_health_and_human_services hhs provide grants states research opioids including heroin opioid abuse prevention treatment department_of_the_treasury transfer equal revenue collected tax hhs carry bill bill makes funds available appropriation designates funding emergency requirement statutory pay act paygo


Summary:
Help Our Neediest Families Act of 2016

This bill amends part A (Temporary Assistance for Needy Families) (TANF) of title IV of the Social Security Act to prohibit a state to which a TANF grant is made from using any part of such grant for drug testing of TANF applicants or recipients.

If the Department of Health and Human Services (HHS) determines that a state has violated such prohibition, it shall reduce the family assistance grant amount payable to the state for the immediately succeeding fiscal year by not more than 1%.

This bill amends the United States Housing Act of 1937 to prohibit drug testing of aid recipients under the housing choice voucher program.

help families act bill amends temporary assistance needy families tanf title social security act prohibit state tanf grant grant drug testing tanf applicants recipients department_of_health_and_human_services hhs determines state violated prohibition shall reduce family assistance grant payable state immediately succeeding fiscal year bill amends united_states housing act prohibit drug testing aid recipients housing choice voucher program


Summary:
(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)

Transnational Drug Trafficking Act of 2015

(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.

Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.

In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.

(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."

measure amended introduced expanded summary senate reported version repeated transnational drug trafficking act sec bill amends controlled_substances_import_and_export_act broaden scope persons subject criminal prosecution manufacturing distributing controlled substance schedule precursor chemical flunitrazepam unlawful import united_states controlled substances act classifies drugs substances chemicals drugs schedules based drug medical use potential abuse risk dependence current law prohibits manufacture distribution person knows intends substance chemical unlawfully imported bill broadens scope prohibit manufacture distribution person reasonably believes substance chemical unlawfully imported addition bill prohibits manufacture distribution precursor chemical person knows intends chemical manufacture controlled substance knows intends reasonably believes controlled substance unlawfully imported united_states sec legislation amends federal criminal code replace statutory references prohibited trafficking counterfeit drug references prohibited trafficking drug uses counterfeit mark connection drug


Summary:
Protecting Our Youth from Dangerous Synthetic Drugs Act of 2015

Amends the Controlled Substances Act to include in the definition of a "controlled substance analogue" a substance designated as such by the Controlled Substance Analogue Committee (established by this Act).

Directs the Attorney General to establish such Committee as an interagency committee headed by the Administrator of the Drug Enforcement Administration (DEA) and comprised of scientific experts in the fields of chemistry and pharmacology from DEA, the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and any other federal agency determined by the Attorney General to be appropriate.

 Requires the Committee to designate, and establish and maintain a list of, controlled substance analogues determined to be similar to a schedule I or II controlled substance in either chemical structure or predictive effect on the body in such a manner as to make it likely that the substance will, or can be reasonably expected to, have a potential for abuse. Directs the Administrator to publish a description of each designation made by the Committee.

Amends the Controlled Substances Import and Export Act to prohibit the importation of any controlled substance analogue except pursuant to such notification or declaration as the Attorney General may prescribe.

Directs the U.S. Sentencing Commission to review and, if appropriate, amend the federal sentencing guidelines and policy statements to ensure that they provide adequate penalties for any offense involving the unlawful manufacturing, importing, exporting, or trafficking of controlled substance analogues and similar offenses.

protecting youth dangerous synthetic drugs act amends controlled substances act include definition controlled substance analogue substance designated established act directs attorney general establish committee interagency committee headed administrator drug_enforcement_administration dea comprised scientific experts fields chemistry pharmacology dea centers_for_disease_control_and_prevention federal agency determined attorney general appropriate requires committee designate establish maintain list controlled substance determined similar schedule controlled substance chemical structure predictive effect body manner likely substance reasonably expected potential abuse directs administrator publish description designation committee amends controlled_substances_import_and_export_act prohibit importation controlled substance analogue pursuant notification declaration attorney general prescribe directs review appropriate amend federal sentencing guidelines policy statements ensure provide adequate penalties offense involving unlawful manufacturing importing exporting trafficking controlled substance similar offenses


Summary:
Industrial Hemp Farming Act of 2015

 Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa L. and any part of such plant, whether growing or not, with a delta-nine tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis. Deems Cannabis sativa L. to meet that concentration limit if a person grows or processes it for purposes of making industrial hemp in accordance with state law, unless the Attorney General determines that the state law is not reasonably calculated to comply with such definition.

industrial hemp farming act amends controlled substances act exclude industrial hemp definition marihuana defines industrial hemp mean plant cannabis sativa plant growing delta tetrahydrocannabinol concentration percent dry weight basis sativa meet concentration limit person grows processes purposes making industrial hemp accordance state law attorney general determines state law reasonably calculated comply definition


Summary:
Fifth Amendment Integrity Restoration Act of 2015 or the FAIR Act

This bill modifies general rules governing civil forfeiture proceedings to: (1) ensure that a person contesting a civil forfeiture has legal representation without regard to whether the property subject to forfeiture is being used by such person as a primary residence; (2) increase the federal government's burden of proof in civil forfeiture proceedings to clear and convincing evidence; (3) require the government, in addition to showing a substantial connection between the seized property and an offense, to establish by clear and convincing evidence that the owner of any interest in the seized property used the property with intent to facilitate the offense or knowingly consented or was willfully blind to the use of the property by another in connection with the offense; and (4) expand the proportionality criteria used by a court to determine whether a civil forfeiture was constitutionally excessive.

To remove incentives for carrying out civil forfeitures, the bill requires proceeds from the disposition of seized property to be deposited into the General Fund of the Treasury, rather than to Department of Justice accounts for law enforcement activities.

The bill adds a scienter requirement (i.e., a knowing violation) to the prohibition against structuring financial transactions to evade reporting requirements.

The bill requires: (1) a court to conduct a probable cause hearing to determine if there is a violation of the prohibition against structuring transactions to evade reporting requirements involving a monetary instrument and to return such instrument if probable cause is not established, and (2) the Attorney General to specify in reports to Congress and the public on forfeitures the amounts received from criminal and civil forfeitures.

fair act bill modifies general rules governing civil forfeiture proceedings ensure person contesting civil forfeiture legal representation regard property subject forfeiture person primary residence increase federal government burden proof civil forfeiture proceedings clear convincing evidence require government addition showing substantial connection seized property offense establish clear convincing evidence owner interest seized property property intent facilitate offense knowingly consented willfully blind use property connection offense expand criteria court determine civil forfeiture constitutionally excessive remove incentives carrying civil forfeitures bill requires proceeds disposition seized property deposited general_fund treasury department_of_justice accounts law enforcement activities bill adds requirement knowing violation prohibition structuring financial transactions evade reporting requirements bill requires court conduct probable cause hearing determine violation prohibition structuring transactions evade reporting requirements involving monetary instrument return instrument probable cause established attorney general specify reports congress public forfeitures amounts received criminal civil forfeitures


Summary:
Protecting Lands Against Narcotics Trafficking Act of 2015 or the PLANT Act

 Amends the Controlled Substances Act to: (1) impose an additional term of up to ten years' imprisonment for cultivating or manufacturing controlled substances on federal property; and (2) apply the prohibition against assembling, maintaining, or placing a booby trap on federal property where a controlled substance is being manufactured to federal property where a controlled substance is being cultivated.

Directs the U.S. Sentencing Commission to amend and review the Federal Sentencing Guidelines to provide for a penalty enhancement of not less than one offense level for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense a controlled substance or a counterfeit substance while on federal property or while intentionally trespassing on the property of another if such offense: (1) creates a hazard to humans, wildlife, or domestic animals; (2) degrades or harms the environment or natural resources; (3) pollutes an aquifer, spring, stream, river, or body of water; (4) involves the diversion, redirection, obstruction, or draining of an aquifer, spring, stream, river, or body of water or the clear cut of timber while cultivating or manufacturing a controlled substance; or (5) involves the possession of a firearm while cultivating or manufacturing controlled substances.

Prohibits, and sets penalties of up to $500,000 for an individual or $1 million for other than an individual for, diverting, redirecting, obstructing, or draining an aquifer, spring, stream, river, or body of water or clear cutting timber while cultivating or manufacturing a controlled substance on federal property or while cultivating or manufacturing a controlled substance while intentionally trespassing on the property of another. Requires such fines to be transferred to the Department of the Interior for use in addressing the environmental damage caused by the offense.

trafficking act plant act amends controlled substances act impose additional term years imprisonment cultivating manufacturing controlled substances federal property apply prohibition assembling maintaining placing trap federal property controlled substance manufactured federal property controlled substance cultivated directs amend review federal sentencing guidelines provide penalty enhancement offense level manufacturing distributing dispensing possessing intent manufacture distribute dispense controlled substance counterfeit substance federal property intentionally trespassing property offense creates hazard humans wildlife domestic animals harms environment natural resources aquifer spring stream river body water involves diversion obstruction draining aquifer spring stream river body water clear cut timber cultivating manufacturing controlled substance involves possession firearm cultivating manufacturing controlled substances prohibits sets penalties individual million individual diverting obstructing draining aquifer spring stream river body water clear cutting timber cultivating manufacturing controlled substance federal property cultivating manufacturing controlled substance intentionally trespassing property requires fines transferred department_of_the_interior use addressing environmental damage caused offense


Summary:
Stop Drugs at the Border Act of 2015

Directs the Office of National Drug Control Policy to ensure that the first update of the National Southwest Border Counternarcotics Strategy published after enactment of this Act specifically addresses any increased heroin and methamphetamine trafficking occurring along the international border between the United States and Mexico.

Requires U.S. Customs and Border Protection (CBP) to report on any new resources needed by CBP and its law enforcement partners to respond to such increased trafficking, including any technology, equipment, personnel, or funding needed.

stop drugs border act ensure update published enactment act specifically addresses increased heroin methamphetamine trafficking occurring international border united_states mexico border protection cbp report new resources needed cbp law enforcement partners respond increased trafficking including technology equipment personnel funding needed


Summary:
(This measure has not been amended since it was reported to the Senate on February 11, 2016. The summary of that version is repeated here.)

Ensuring Patient Access and Effective Drug Enforcement Act of 2016

(Sec. 2) This bill amends the Controlled Substances Act to define phrases related to the Drug Enforcement Administration's (DEA's) authority to register manufacturers, distributors, and dispensers of controlled substances.

Currently, the DEA registers a controlled substances manufacturer, distributor, or dispenser if it is in the public interest after considering certain factors, including factors relevant to and consistent with the public health and safety. This bill defines "factors as may be relevant to and consistent with the public health and safety" to mean factors relevant to and consistent with the specified purposes of the Controlled Substances Act.

Additionally, current law allows the DEA to immediately suspend a registration to prevent imminent danger to the public health and safety. This bill defines "imminent danger to the public health and safety" to mean an immediate threat of death, serious bodily harm, or abuse of a controlled substance due to a registrant's failure to maintain effective controls against diversion.

The bill revises and expands the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a Controlled Substances Act violation. An order to show cause must specifically state the legal basis for the action and notify the registrant of the opportunity to submit a corrective action plan.

(Sec. 3) The Food and Drug Administration, the Substance Abuse and Mental Health Services Administration, the Agency for Research and Quality, and the Centers for Disease Control and Prevention, in coordination with the DEA, must report to Congress on:

 obstacles to legitimate patient access to controlled substances; diversion of controlled substances; how collaboration between law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances; the availability of and gaps in medical education, training opportunities, and comprehensive clinical guidance for pain management and opioid prescribing; enhancements to prescription drug monitoring programs; and improvements to prescription opioid reporting requirements.

measure amended reported senate february summary version repeated ensuring patient access effective drug enforcement act sec bill amends controlled substances act define phrases related drug_enforcement_administration dea authority register manufacturers distributors dispensers controlled substances currently dea registers controlled substances manufacturer distributor dispenser public interest considering certain factors including factors relevant consistent public health safety bill defines factors relevant consistent public health safety mean factors relevant consistent specified purposes controlled substances act additionally current law allows dea immediately suspend registration prevent imminent danger public health safety bill defines imminent danger public health safety mean immediate threat death bodily harm abuse controlled substance registrant failure maintain effective controls diversion bill revises expands required elements order cause issued dea denies revokes suspends registration controlled substances act violation order cause specifically state legal basis action notify registrant opportunity submit corrective action plan sec food_and_drug_administration substance_abuse_and_mental_health_services_administration agency research quality centers_for_disease_control_and_prevention coordination dea report congress obstacles legitimate patient access controlled substances diversion controlled substances collaboration law enforcement agencies pharmaceutical industry benefit patients prevent diversion abuse controlled substances availability gaps medical education training opportunities comprehensive clinical guidance pain management opioid prescribing enhancements prescription drug monitoring programs improvements prescription opioid reporting requirements